Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
31.92Price to Sales
VS
Market
Sector
Industry
History
$ 0.46Close
$ 0.41 - $ 3.18 52-Week Range
Ticker Information
Ticker
RANICompany Name
RANI THERAPEUTICS HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQRANI THERAPEUTICS HOLDINGS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RANI - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 38.31M | 31.92 | $ 1.2M |
| 3/31/2025 | $ 27.74M | 23.11 | $ 1.2M |
| 12/31/2024 | $ 72.43M | 70.45 | $ 1.03M |
| 9/30/2024 | $ 134.63M | 0 | $ 0 |
| 6/30/2024 | $ 133.52M | 0 | $ 0 |
| 3/31/2024 | $ 381.18M | 0 | $ 0 |
| 12/31/2023 | $ 179.06M | 0 | $ 0 |
| 9/30/2023 | $ 98.99M | 0 | $ 0 |
| 6/30/2023 | $ 208.52M | 0 | $ 0 |
| 3/31/2023 | $ 212.82M | 0 | $ 0 |
Key Performance Insights, Last 5 Years
- RANI THERAPEUTICS HOLDINGS INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, RANI THERAPEUTICS HOLDINGS INC's average P/S has been 127.1.
- The median P/S for RANI THERAPEUTICS HOLDINGS INC during this period was 70.45
- RANI THERAPEUTICS HOLDINGS INC reached its highest P/S over the past 5 years at 265.73.
- The lowest P/S recorded by RANI THERAPEUTICS HOLDINGS INC in the same timeframe 23.11
RANI THERAPEUTICS HOLDINGS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for RANI THERAPEUTICS HOLDINGS INC is calculated as follows: Market Cap [ $ 0 ] / Revenues [ $ 462K ]
(=) P/S [ 0 ] RANI - Price to Sales, Last 5 years
23.11
Minimum
Mar 31, 2025
265.73
Maximum
Mar 31, 2022
127.1
Average
70.45
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.41K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |